ARQT
Arcutis BiotherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
ARQT vs peer average
66/100
ARQT vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ADPT is the first available peer comparator.
Adaptive Biotechnologies is a loose small/mid-cap biotech peer by market cap, but its immune-diagnostics profile limits commercial read-through for Arcutis.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARQT
Arcutis Biotherapeutics
ADPT
Adaptive Biotechnologies
Grade
B
D
Momentum
84
97
Value
49
41
Sentiment
42
20
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ADPT
ARQT / ADPT
Grade Position
In line
ARQT vs. peer average (B vs. C)
66/100
Momentum
84
ADPTValue
49
ARQTSentiment
42
ARQTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARQT
ADPT is the first peer returned for this comparison set.